Stay updated with breaking news from Glen Clack. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Evgen Pharma PLC on Tuesday said final data from a trial of its SFX-01 therapy has shown a new formulation of the drug is safe. The Cheshire, England-based clinical stage drug development company... -Today at 05:02 am- MarketScreener
Evgen Pharma PLC (AIM:EVG) chief medical officer Dr Glen Clack takes the opportunity presented by Glioblastoma Awareness Day to speak with Thomas Warner...
Investegate announcements from Evgen Pharma PLC, Full Year Results
Investegate announcements from Evgen Pharma PLC, Grant of Options
26 April 2021 | 09:34am StockMarketWire.com - Clinical stage drug development company Evgen said had appointed Glen Clack, MD, FFPM as chief medical officer starting from 1 May 2021. 'Clack has over 30 years' experience in oncology and translational medicine, and held various roles within AstraZeneca for almost 20 years,' the company said. At 9:34am: [LON:EVG] Evgen Pharma Plc share price was 0p at 8.3p Story provided by StockMarketWire.com Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account. Latest share price and company details: